Oxford Instruments issues profit warning and cuts jobs
This article was originally published in Clinica
Oxford Instruments is to cut 120 jobs in the UK as part of restructuring measures aimed at improving efficiency and cutting costs. The UK company also issued a profit warning for the first six months. Shares in the company fell by 25p to 202.5p ($3.23) on news of the two developments.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.